Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Visual and surgical outcomes of MMC augmented combined non-penetrating deep sclerectomy and phacoemulsification in eyes with severe and end stage glaucoma

Abstract

Purpose

To report the visual and surgical outcomes of mitomycin-C (MMC) augmented non-penetrating deep sclerectomy (NPDS) and phacoemulsification in patients with severe and end-stage glaucoma.

Materials and methods

A retrospective analysis of 349 eyes of 320 patients who underwent combined NPDS with phacoemulsification surgery between January 2018 to December 2020 were included.

Main outcome measures

Best corrected visual acuity (BCVA), status of central visual fields, intra ocular pressure (IOP), number of antiglaucoma medications (AGM) were compared from baseline to post-operative visits, surgical complications and interventions were noted.

Results

Mean logMAR BCVA improved significantly from baseline of 0.54 ± 0.42 to 0.30 ± 0.37 & 0.29 ± 0.40 at 6(p < 0.001) & 12 months (p < 0.001) postoperatively. HFA 10-2 analysis revealed no significant post operative change in mean deviation from baseline at 6 & 12 months (p = 0.072, p = 0.143) respectively. Significant post-operative reduction in mean (SD) IOP was noted from baseline of 17.54(5.43) mmHg to 15.10(5.34) & 16.23(6.87) mmHg at 6 months(p < 0.001) and one year(p < 0.001) respectively. Similarly, the need for AGM also reduced significantly from 2.95(1.01) to 1.93(0.98) & 2.01 (0.99) at 6 (p < 0.001)& 12 months(p < 0.001) postoperatively. Cumulative surgical success was 95% and 93% at 6 months and 1 year respectively. Complications were seen in 17.8% patients and most were related to poor IOP control (8.3%). Two (0.6%) patients underwent tube surgery and 3 (0.9%) had undergone diode laser cyclophotocoagulation for refractory high IOP.

Conclusion

MMC augmented NPDS combined with phacoemulsification surgery is a safe and a viable option in eyes with advanced glaucoma maintaining stable visual acuity and visual fields postoperatively.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

Similar content being viewed by others

References

  1. Kastner A, King AJ. Advanced glaucoma at diagnosis: current perspectives. Eye (Lond). 2020;34:116–28.

    PubMed  Google Scholar 

  2. Mokhles P, Schouten JSAG, Beckers HJM, Azuara-Blanco A, Tuulonen A, Webers CAB. A systematic review of end-of-life visual impairment in open-angle glaucoma: an epidemiological autopsy. J Glaucoma. 2016;25:623–8.

    PubMed  Google Scholar 

  3. Lee JM, Caprioli J, Nouri-Mahdavi K, Afifi AA, Morales E, Ramanathan M, et al. Baseline prognostic factors predict rapid visual field deterioration in glaucoma. Invest Ophthalmol Vis Sci. 2014;554:2228–36.

    Google Scholar 

  4. Anon. The Advanced Glaucoma Intervention Study (AGIS): 7.The relationship between control of intraocular pressure and visual field deterioration. AGIS Investig Am J Ophthalmol. 2000;1304:429–40.

    Google Scholar 

  5. King AJ, Hudson J, Fernie G, Kernohan A, Azuara-Blanco A, Burr J, et al. Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS). BMJ. 2021;373:n1014.

    PubMed  PubMed Central  Google Scholar 

  6. DeBry PW, Perkins TW, Heatley G, Kaufman P, Brumback LC. Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol. 2002;120:297–300.

    CAS  PubMed  Google Scholar 

  7. Gedde SJ, Feuer WJ, Lim KS, Barton K, Goyal S, Ahmed II, et al. Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 5 Years of Follow-up. Ophthalmology. 2022;129:1344–56.

    PubMed  Google Scholar 

  8. Leleu I, Penaud B, Blumen-Ohana E, Rodallec T, Adam R, Laplace O, et al. Central 10-degree visual field change following non-penetrating deep sclerectomy in severe and end-stage glaucoma: preliminary results. Graefes Arch Clin Exp Ophthalmol. 2018;256:1489–98.

    PubMed  Google Scholar 

  9. Panigrahi A, Kumar A, Gupta S, Grover DS, Gupta V Outcomes of gonioscopy-assisted transluminal trabeculotomy in advanced pigmentary glaucoma. Br J Ophthalmol. 2024: bjo-2024-325749.

  10. Costa VP, Smith M, Spaeth GL, Gandham S, Markovitz B. Loss of visual acuity after trabeculectomy. Ophthalmology. 1993;100:599–612.

    CAS  PubMed  Google Scholar 

  11. Kirwan JF, Lockwood AJ, Shah P, Macleod A, Broadway DC, King AJ, et al. Trabeculectomy in the 21st century: a multicenter analysis. Ophthalmology. 2013;120:2532–9.

    PubMed  Google Scholar 

  12. El Sayyad F, Helal M, El-Kholify H, Khalil M, El-Maghraby A. Nonpenetrating deep sclerectomy versus trabeculectomy in bilateral primary open-angle glaucoma. Ophthalmology. 2000;107:1671–4.

    CAS  PubMed  Google Scholar 

  13. Chiselita D. Non-penetrating deep sclerectomy versus trabeculectomy in primary open-angle glaucoma surgery. Eye (Lond). 2001;15:197–201.

    CAS  PubMed  Google Scholar 

  14. Dwivedi R, Somerville T, Cheeseman R, Rogers C, Batterbury M, Choudhary A. Deep sclerectomy and trabeculectomy augmented with Mitomycin C: 2-year post-operative outcomes. Graefes Arch Clin Exp Ophthalmol. 2021;259:1965–74.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Shaarawy T, Mansouri K, Schnyder C, Ravinet E, Achache F, Mermoud A. Long-term results of deep sclerectomy with collagen implant. J Cataract Refract Surg. 2004;30:1225–31.

    PubMed  Google Scholar 

  16. Kozobolis VP, Christodoulakis EV, Tzanakis N, Zacharopoulos I, Pallikaris IG. Primary deep sclerectomy versus primary deep sclerectomy with the use of mitomycin C in primary open-angle glaucoma. J Glaucoma. 2002;11:287–93.

    PubMed  Google Scholar 

  17. Ates H, Andac K, Uretmen O. Non-penetrating deep sclerectomy and collagen implant surgery in glaucoma patients with advanced field loss. Int Ophthalmol. 1999;23:123–8.

    CAS  PubMed  Google Scholar 

  18. Mills RP, Budenz DL, Lee PP, Noecker RJ, Walt JG, Siegartel LR, et al. Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease. Am J Ophthalmol. 2006;141:24–30.

    PubMed  Google Scholar 

  19. Law SK, Nguyen AM, Coleman AL, Caprioli J. Severe loss of central vision in patients with advanced glaucoma undergoing trabeculectomy. Arch Ophthalmol. 2007;125:1044–50.

    PubMed  Google Scholar 

  20. Bengtsson B, Heijl A. False-negative responses in glaucoma perimetry: indicators of patient performance or test reliability? Am J Ophthalmol. 2000;130:689.

    CAS  PubMed  Google Scholar 

  21. Oh LJ, Wong E, Lam J, Clement CI. Comparison of bleb morphology between trabeculectomy and deep sclerectomy using a clinical grading scale and anterior segment optical coherence tomography. Clin Exp Ophthalmol. 2017;45:701–7.

    PubMed  Google Scholar 

  22. Richardson-May J, Alnuaimi R, Elbably A, Walker L, Thulasidharan S, Dacombe R, et al. Our experience of deep sclerectomy at a tertiary center in the United Kingdom Over 14 Years. Cureus. 2023;15:e43366.

    PubMed  PubMed Central  Google Scholar 

  23. Anand N, Atherley C. Deep sclerectomy augmented with mitomycin C. Eye (Lond). 2005;19:442–50.

    CAS  PubMed  Google Scholar 

  24. Cheng J-W, Cai J-P, Li Y, Wei R-L. Intraoperative mitomycin C for nonpenetrating glaucoma surgery: a systematic review and meta-analysis. J Glaucoma. 2011;20:322–6.

    PubMed  Google Scholar 

  25. Mercieca K, Shevade B, Anand N. Outcomes of combined phacoemulsification and deep sclerectomy: a 10-year UK single-centre study. Eye (Lond). 2015;29:1495–503.

    CAS  PubMed  Google Scholar 

  26. Di Matteo F, Bettin P, Fiori M, Ciampi C, Rabiolo A, Bandello F. Nd:Yag laser goniopuncture for deep sclerectomy: efficacy and outcomes. Graefes Arch Clin Exp Ophthalmol. 2016;254:535–9.

    PubMed  Google Scholar 

  27. Koukkoulli A, Musa F, Anand N. Long-term outcomes of needle revision of failing deep sclerectomy blebs. Graefes Arch Clin Exp Ophthalmol. 2015;253:99–106.

    PubMed  Google Scholar 

  28. Denis D, Pommier S, Coste R, Fogliarini C, Benso C, Cornand E. [Deep sclerectomy in congenital glaucoma: results of a study lasting more than 3 years]. J Fr Ophtalmol. 2008;31:173–9.

    CAS  PubMed  Google Scholar 

  29. Elhofi A, Helaly HA. Non-Penetrating Deep Sclerectomy versus Trabeculectomy in Primary Congenital Glaucoma. Clin Ophthalmol. 2020;14:1277–85.

    PubMed  PubMed Central  Google Scholar 

  30. Rabiolo A, Leadbetter D, Alaghband P, Anand N. Primary deep sclerectomy in open-angle glaucoma: long-term outcomes and risk factors for failure. Ophthalmol Glaucoma. 2021;4:149–61.

    PubMed  Google Scholar 

  31. Rulli E, Biagioli E, Riva I, Gambirasio G, De Simone I, Floriani I, et al. Efficacy and safety of trabeculectomy vs nonpenetrating surgical procedures: a systematic review and meta-analysis. JAMA Ophthalmol. 2013;131:1573–82.

    CAS  PubMed  Google Scholar 

  32. Yuen NSY, Chan OCC, Hui SP, Ching RHY. Combined phacoemulsification and nonpenetrating deep sclerectomy in the treatment of chronic angle-closure glaucoma with cataract. Eur J Ophthalmol. 2007;17:208–15.

    CAS  PubMed  Google Scholar 

  33. Xiao J-Y, Liang A-Y, Wang Y-L, Cheng G-W, Zhang M-F. Efficacy and safety of non-penetrating glaucoma surgery with phacoemulsification versus non-penetrating glaucoma surgery: a Meta-analysis. Int J Ophthalmol. 2021;14:1970–8.

    PubMed  PubMed Central  Google Scholar 

  34. Kleinmann G, Katz H, Pollack A, Schechtman E, Rachmiel R, Zalish M. Comparison of trabeculectomy with mitomycin C with or without phacoemulsification and lens implantation. Ophthalmic Surg Lasers. 2002;33:102–8.

    PubMed  Google Scholar 

  35. Lochhead J, Casson RJ, Salmon JF. Long term effect on intraocular pressure of phacotrabeculectomy compared to trabeculectomy. Br J Ophthalmol. 2003;87:850–2.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Gianoli F, Schnyder CC, Bovey E, Mermoud A. Combined surgery for cataract and glaucoma: phacoemulsification and deep sclerectomy compared with phacoemulsification and trabeculectomy. J Cataract Refract Surg. 1999;25:340–6.

    CAS  PubMed  Google Scholar 

  37. Stead RE, King AJ. Outcome of trabeculectomy with mitomycin C in patients with advanced glaucoma. Br J Ophthalmol. 2011;95:960–5.

    PubMed  Google Scholar 

  38. Edmunds B, Thompson JR, Salmon JF, Wormald RP. The National Survey of Trabeculectomy. III. Early and late complications. Eye (Lond). 2002;16:297–303.

    CAS  PubMed  Google Scholar 

  39. Mendrinos E, Mermoud A, Shaarawy T. Nonpenetrating glaucoma surgery. Surv Ophthalmol. 2008;53:592–630.

    PubMed  Google Scholar 

  40. Mercieca K, Steeples L, Anand N. Medscape. Deep sclerectomy for uveitic glaucoma: long-term outcomes. Eye (Lond). 2017;31:1008–19.

    CAS  PubMed  Google Scholar 

  41. Suominen S, Harju M, Ihanamäki T, Vesti E. The effect of deep sclerectomy on intraocular pressure of normal-tension glaucoma patients: 1-year results. Acta Ophthalmol. 2010;88:27–32.

    PubMed  Google Scholar 

  42. Elhofi A, Helaly HA. Outcome of primary nonpenetrating deep sclerectomy in patients with steroid-induced glaucoma. J Ophthalmol. 2018;2018:9215650.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Concepts: RS, VAS. Design: RS, VAS. Definition of intellectual content: RS, TS, MR, VAS. Literature search: RS, TS, MR, JK, VAS. Clinical studies: RS, JK, KBS, VAS. Experimental studies: RS, TS. Data acquisition: TS, MR, JK. Data analysis: KBS. Statistical analysis: KBS. Manuscript preparation: RS, TS, MR, JK, VAS. Manuscript editing: RS, KBS, VAS. Manuscript review: RS, KBS, VAS. Guarantor: RS, VAS.

Corresponding author

Correspondence to Vijayalakshmi A. Senthilkumar.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sharmila, R., Sruthi, T., Rao, M. et al. Visual and surgical outcomes of MMC augmented combined non-penetrating deep sclerectomy and phacoemulsification in eyes with severe and end stage glaucoma. Eye 39, 1571–1577 (2025). https://doi.org/10.1038/s41433-025-03719-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41433-025-03719-z

Search

Quick links